Neurocysticercosis :: from diagnosis to treatment /
"Neurocysticercosis, a preventable parasitic infection of the central nervous system caused by tapeworm, is a serious, potentially fatal disease that can cause neurologic syndromes such as epileptic seizures. Chapter One of this monograph describes the existing treatment options for neurocystic...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Science Publishers,
[2021]
|
| Schriftenreihe: | Neuroscience research progress
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "Neurocysticercosis, a preventable parasitic infection of the central nervous system caused by tapeworm, is a serious, potentially fatal disease that can cause neurologic syndromes such as epileptic seizures. Chapter One of this monograph describes the existing treatment options for neurocysticercosis, along with possible therapeutic alternatives under different drug development phases. Chapter Two explains the difficulties associated with correctly diagnosing neurocysticercosis, resulting from its varied clinical presentation, and mentions current guidelines of diagnostic criteria for neurocysticercosis. Chapter Three describes the various merits and demerits of techniques for detecting the parasites associated with neurocysticercosis, which include radioimaging, genotyping of cysts, and antibody, antigen, and nucleic acid detection in body fluids"-- |
| Beschreibung: | 1 online resource. |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 1536198250 9781536198256 |
Internformat
MARC
| LEADER | 00000cam a22000008i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1257479891 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 210617s2021 nyu ob 001 0 eng | ||
| 010 | |a 2021030102 | ||
| 040 | |a DLC |b eng |e rda |c DLC |d OCLCO |d N$T |d OCLCF |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d TMA |d OCLCQ |d QGK |d OCLCQ | ||
| 020 | |a 1536198250 | ||
| 020 | |a 9781536198256 |q (electronic bk.) | ||
| 020 | |z 9781536197914 |q (paperback) | ||
| 035 | |a (OCoLC)1257479891 | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a QP370 |
| 082 | 7 | |a 612.8/2 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Neurocysticercosis : |b from diagnosis to treatment / |c Mark A. Chavez, editor. |
| 263 | |a 2108 | ||
| 264 | 1 | |a New York : |b Nova Science Publishers, |c [2021] | |
| 300 | |a 1 online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Neuroscience research progress | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a "Neurocysticercosis, a preventable parasitic infection of the central nervous system caused by tapeworm, is a serious, potentially fatal disease that can cause neurologic syndromes such as epileptic seizures. Chapter One of this monograph describes the existing treatment options for neurocysticercosis, along with possible therapeutic alternatives under different drug development phases. Chapter Two explains the difficulties associated with correctly diagnosing neurocysticercosis, resulting from its varied clinical presentation, and mentions current guidelines of diagnostic criteria for neurocysticercosis. Chapter Three describes the various merits and demerits of techniques for detecting the parasites associated with neurocysticercosis, which include radioimaging, genotyping of cysts, and antibody, antigen, and nucleic acid detection in body fluids"-- |c Provided by publisher. | ||
| 588 | |a Description based on print version record and CIP data provided by publisher; resource not viewed. | ||
| 505 | 0 | |a Intro -- Contents -- Preface -- Treatment of Neurocysticercosis: Current and Future Options -- Abstract -- Introduction -- Life Cycle -- Clinical Manifestations of NCC -- Pathology of NCC -- Extraparenchymal NCC -- Other forms of NCC -- Existing Treatment -- Symptomatic Therapy -- Corticosteroids -- Antiepileptic Drugs (AEDs) -- Anti-Parasitic/Cysticidal Therapy -- Surgery -- Limitations of Approved Cysticidal Drugs -- Repositioned Drugs -- Nitazoxanide -- Mepacrine/Quinacrine -- Tribendimidine -- Paromomycin -- Tamoxifen -- Metrifonate (Trichlorfon) -- Potential/Novel Drug Targets -- Protein Kinases -- Proteases -- Estrogen Receptor-Like Proteins -- Insulin Receptors -- Acetylcholinesterase's -- G-Protein-Coupled Receptors -- Parasite Antioxidant Enzyme -- Plasminogen and Plasmin -- Future Perspectives -- References -- The Challenge of Deciphering Certainty from Ambiguity for the Laboratory Diagnosis of Neurocysticercosis -- 1. Introduction -- 2. Guidelines for NCC Diagnosis -- 3. Available Diagnostic Tools for NCC -- 3.1. Neuroimaging Techniques (MRI and CT) -- 3.1.1. Sero-Diagnostic Tools -- 3.1.2. Enzyme Electro-Immune Transfer Blot -- 3.1.3. Enzyme Linked Immunosorbent Assay (ELISA) -- 3.1.4. Sandwich ELISA -- 3.1.5. Direct ELISA -- 3.1.6. Antibody ELISA -- 3.1.7. DOT ELISA -- 3.1.8. Molecular Assay and New Age Tools -- 3.1.9. Polymerase Chain Reaction -- 3.1.10. TaqMan PCR -- 3.1.11. Quantitative PCR (qPCR) -- 3.1.12. Multiplex PCR -- 3.1.13. Lymphocyte Transformation Test (LTT) -- 3.1.14. Loop Mediated Isothermal Amplification (LAMP) -- 3.1.15. Magnetic Resonance Spectroscopy (MRS) -- 3.1.16. miRNA -- 3.1.17. Exosome's Detection -- Conclusion -- References -- Trends in the Diagnosis of Human Neurocysticercosis: Issues and Challenges -- Abstract -- Introduction -- Antibody Detection -- Crude Soluble Extract Antigens. | |
| 505 | 8 | |a Excretory-Secretory Antigens -- Purified Antigenic Fractions -- Recombinant Antigens -- Antigen Detection -- Urine and Saliva Samples -- Nucleic Acid Detection -- Polymerase Chain Reaction (PCR) -- Loop-Mediated Isothermal Amplification (LAMP) -- Genotype Variation in the Parasite -- Proteomics -- Cell Mediated Techniques -- Clinical Considerations -- Presentation vs. Diagnosis -- Single vs. Multiple Lesions -- Childhood NCC -- Post-Treatment Follow-Up -- Conclusion -- References -- Index -- Blank Page. | |
| 650 | 0 | |a Central nervous system. |0 http://id.loc.gov/authorities/subjects/sh85021906 | |
| 650 | 0 | |a Cysticercosis. |0 http://id.loc.gov/authorities/subjects/sh85035207 | |
| 650 | 2 | |a Central Nervous System |0 https://id.nlm.nih.gov/mesh/D002490 | |
| 650 | 2 | |a Cysticercosis |0 https://id.nlm.nih.gov/mesh/D003551 | |
| 650 | 6 | |a Système nerveux central. | |
| 650 | 6 | |a Cysticercose. | |
| 650 | 7 | |a Central nervous system |2 fast | |
| 650 | 7 | |a Cysticercosis |2 fast | |
| 700 | 1 | |a Chavez, Mark A., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Neurocysticercosis |d New York : Nova Science Publishers, [2021] |z 9781536197914 |w (DLC) 2021030101 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2944021 |3 Volltext |
| 938 | |a YBP Library Services |b YANK |n 302282673 | ||
| 938 | |a EBSCOhost |b EBSC |n 2944021 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1257479891 |
|---|---|
| _version_ | 1816882546128977920 |
| adam_text | |
| any_adam_object | |
| author2 | Chavez, Mark A. |
| author2_role | edt |
| author2_variant | m a c ma mac |
| author_facet | Chavez, Mark A. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QP370 |
| callnumber-raw | QP370 |
| callnumber-search | QP370 |
| callnumber-sort | QP 3370 |
| callnumber-subject | QP - Physiology |
| collection | ZDB-4-EBA |
| contents | Intro -- Contents -- Preface -- Treatment of Neurocysticercosis: Current and Future Options -- Abstract -- Introduction -- Life Cycle -- Clinical Manifestations of NCC -- Pathology of NCC -- Extraparenchymal NCC -- Other forms of NCC -- Existing Treatment -- Symptomatic Therapy -- Corticosteroids -- Antiepileptic Drugs (AEDs) -- Anti-Parasitic/Cysticidal Therapy -- Surgery -- Limitations of Approved Cysticidal Drugs -- Repositioned Drugs -- Nitazoxanide -- Mepacrine/Quinacrine -- Tribendimidine -- Paromomycin -- Tamoxifen -- Metrifonate (Trichlorfon) -- Potential/Novel Drug Targets -- Protein Kinases -- Proteases -- Estrogen Receptor-Like Proteins -- Insulin Receptors -- Acetylcholinesterase's -- G-Protein-Coupled Receptors -- Parasite Antioxidant Enzyme -- Plasminogen and Plasmin -- Future Perspectives -- References -- The Challenge of Deciphering Certainty from Ambiguity for the Laboratory Diagnosis of Neurocysticercosis -- 1. Introduction -- 2. Guidelines for NCC Diagnosis -- 3. Available Diagnostic Tools for NCC -- 3.1. Neuroimaging Techniques (MRI and CT) -- 3.1.1. Sero-Diagnostic Tools -- 3.1.2. Enzyme Electro-Immune Transfer Blot -- 3.1.3. Enzyme Linked Immunosorbent Assay (ELISA) -- 3.1.4. Sandwich ELISA -- 3.1.5. Direct ELISA -- 3.1.6. Antibody ELISA -- 3.1.7. DOT ELISA -- 3.1.8. Molecular Assay and New Age Tools -- 3.1.9. Polymerase Chain Reaction -- 3.1.10. TaqMan PCR -- 3.1.11. Quantitative PCR (qPCR) -- 3.1.12. Multiplex PCR -- 3.1.13. Lymphocyte Transformation Test (LTT) -- 3.1.14. Loop Mediated Isothermal Amplification (LAMP) -- 3.1.15. Magnetic Resonance Spectroscopy (MRS) -- 3.1.16. miRNA -- 3.1.17. Exosome's Detection -- Conclusion -- References -- Trends in the Diagnosis of Human Neurocysticercosis: Issues and Challenges -- Abstract -- Introduction -- Antibody Detection -- Crude Soluble Extract Antigens. Excretory-Secretory Antigens -- Purified Antigenic Fractions -- Recombinant Antigens -- Antigen Detection -- Urine and Saliva Samples -- Nucleic Acid Detection -- Polymerase Chain Reaction (PCR) -- Loop-Mediated Isothermal Amplification (LAMP) -- Genotype Variation in the Parasite -- Proteomics -- Cell Mediated Techniques -- Clinical Considerations -- Presentation vs. Diagnosis -- Single vs. Multiple Lesions -- Childhood NCC -- Post-Treatment Follow-Up -- Conclusion -- References -- Index -- Blank Page. |
| ctrlnum | (OCoLC)1257479891 |
| dewey-full | 612.8/2 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 612 - Human physiology |
| dewey-raw | 612.8/2 |
| dewey-search | 612.8/2 |
| dewey-sort | 3612.8 12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05307cam a22005418i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1257479891</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">210617s2021 nyu ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2021030102</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">DLC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">TMA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">QGK</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1536198250</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781536198256</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781536197914</subfield><subfield code="q">(paperback)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1257479891</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">QP370</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">612.8/2</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Neurocysticercosis :</subfield><subfield code="b">from diagnosis to treatment /</subfield><subfield code="c">Mark A. Chavez, editor.</subfield></datafield><datafield tag="263" ind1=" " ind2=" "><subfield code="a">2108</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Science Publishers,</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neuroscience research progress</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"Neurocysticercosis, a preventable parasitic infection of the central nervous system caused by tapeworm, is a serious, potentially fatal disease that can cause neurologic syndromes such as epileptic seizures. Chapter One of this monograph describes the existing treatment options for neurocysticercosis, along with possible therapeutic alternatives under different drug development phases. Chapter Two explains the difficulties associated with correctly diagnosing neurocysticercosis, resulting from its varied clinical presentation, and mentions current guidelines of diagnostic criteria for neurocysticercosis. Chapter Three describes the various merits and demerits of techniques for detecting the parasites associated with neurocysticercosis, which include radioimaging, genotyping of cysts, and antibody, antigen, and nucleic acid detection in body fluids"--</subfield><subfield code="c">Provided by publisher.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record and CIP data provided by publisher; resource not viewed.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Contents -- Preface -- Treatment of Neurocysticercosis: Current and Future Options -- Abstract -- Introduction -- Life Cycle -- Clinical Manifestations of NCC -- Pathology of NCC -- Extraparenchymal NCC -- Other forms of NCC -- Existing Treatment -- Symptomatic Therapy -- Corticosteroids -- Antiepileptic Drugs (AEDs) -- Anti-Parasitic/Cysticidal Therapy -- Surgery -- Limitations of Approved Cysticidal Drugs -- Repositioned Drugs -- Nitazoxanide -- Mepacrine/Quinacrine -- Tribendimidine -- Paromomycin -- Tamoxifen -- Metrifonate (Trichlorfon) -- Potential/Novel Drug Targets -- Protein Kinases -- Proteases -- Estrogen Receptor-Like Proteins -- Insulin Receptors -- Acetylcholinesterase's -- G-Protein-Coupled Receptors -- Parasite Antioxidant Enzyme -- Plasminogen and Plasmin -- Future Perspectives -- References -- The Challenge of Deciphering Certainty from Ambiguity for the Laboratory Diagnosis of Neurocysticercosis -- 1. Introduction -- 2. Guidelines for NCC Diagnosis -- 3. Available Diagnostic Tools for NCC -- 3.1. Neuroimaging Techniques (MRI and CT) -- 3.1.1. Sero-Diagnostic Tools -- 3.1.2. Enzyme Electro-Immune Transfer Blot -- 3.1.3. Enzyme Linked Immunosorbent Assay (ELISA) -- 3.1.4. Sandwich ELISA -- 3.1.5. Direct ELISA -- 3.1.6. Antibody ELISA -- 3.1.7. DOT ELISA -- 3.1.8. Molecular Assay and New Age Tools -- 3.1.9. Polymerase Chain Reaction -- 3.1.10. TaqMan PCR -- 3.1.11. Quantitative PCR (qPCR) -- 3.1.12. Multiplex PCR -- 3.1.13. Lymphocyte Transformation Test (LTT) -- 3.1.14. Loop Mediated Isothermal Amplification (LAMP) -- 3.1.15. Magnetic Resonance Spectroscopy (MRS) -- 3.1.16. miRNA -- 3.1.17. Exosome's Detection -- Conclusion -- References -- Trends in the Diagnosis of Human Neurocysticercosis: Issues and Challenges -- Abstract -- Introduction -- Antibody Detection -- Crude Soluble Extract Antigens.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Excretory-Secretory Antigens -- Purified Antigenic Fractions -- Recombinant Antigens -- Antigen Detection -- Urine and Saliva Samples -- Nucleic Acid Detection -- Polymerase Chain Reaction (PCR) -- Loop-Mediated Isothermal Amplification (LAMP) -- Genotype Variation in the Parasite -- Proteomics -- Cell Mediated Techniques -- Clinical Considerations -- Presentation vs. Diagnosis -- Single vs. Multiple Lesions -- Childhood NCC -- Post-Treatment Follow-Up -- Conclusion -- References -- Index -- Blank Page.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Central nervous system.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85021906</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cysticercosis.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85035207</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Central Nervous System</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D002490</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Cysticercosis</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D003551</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Système nerveux central.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cysticercose.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Central nervous system</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cysticercosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chavez, Mark A.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Neurocysticercosis</subfield><subfield code="d">New York : Nova Science Publishers, [2021]</subfield><subfield code="z">9781536197914</subfield><subfield code="w">(DLC) 2021030101</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2944021</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">302282673</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2944021</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1257479891 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:30:20Z |
| institution | BVB |
| isbn | 1536198250 9781536198256 |
| language | English |
| lccn | 2021030102 |
| oclc_num | 1257479891 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource. |
| psigel | ZDB-4-EBA |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Nova Science Publishers, |
| record_format | marc |
| series2 | Neuroscience research progress |
| spelling | Neurocysticercosis : from diagnosis to treatment / Mark A. Chavez, editor. 2108 New York : Nova Science Publishers, [2021] 1 online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier Neuroscience research progress Includes bibliographical references and index. "Neurocysticercosis, a preventable parasitic infection of the central nervous system caused by tapeworm, is a serious, potentially fatal disease that can cause neurologic syndromes such as epileptic seizures. Chapter One of this monograph describes the existing treatment options for neurocysticercosis, along with possible therapeutic alternatives under different drug development phases. Chapter Two explains the difficulties associated with correctly diagnosing neurocysticercosis, resulting from its varied clinical presentation, and mentions current guidelines of diagnostic criteria for neurocysticercosis. Chapter Three describes the various merits and demerits of techniques for detecting the parasites associated with neurocysticercosis, which include radioimaging, genotyping of cysts, and antibody, antigen, and nucleic acid detection in body fluids"-- Provided by publisher. Description based on print version record and CIP data provided by publisher; resource not viewed. Intro -- Contents -- Preface -- Treatment of Neurocysticercosis: Current and Future Options -- Abstract -- Introduction -- Life Cycle -- Clinical Manifestations of NCC -- Pathology of NCC -- Extraparenchymal NCC -- Other forms of NCC -- Existing Treatment -- Symptomatic Therapy -- Corticosteroids -- Antiepileptic Drugs (AEDs) -- Anti-Parasitic/Cysticidal Therapy -- Surgery -- Limitations of Approved Cysticidal Drugs -- Repositioned Drugs -- Nitazoxanide -- Mepacrine/Quinacrine -- Tribendimidine -- Paromomycin -- Tamoxifen -- Metrifonate (Trichlorfon) -- Potential/Novel Drug Targets -- Protein Kinases -- Proteases -- Estrogen Receptor-Like Proteins -- Insulin Receptors -- Acetylcholinesterase's -- G-Protein-Coupled Receptors -- Parasite Antioxidant Enzyme -- Plasminogen and Plasmin -- Future Perspectives -- References -- The Challenge of Deciphering Certainty from Ambiguity for the Laboratory Diagnosis of Neurocysticercosis -- 1. Introduction -- 2. Guidelines for NCC Diagnosis -- 3. Available Diagnostic Tools for NCC -- 3.1. Neuroimaging Techniques (MRI and CT) -- 3.1.1. Sero-Diagnostic Tools -- 3.1.2. Enzyme Electro-Immune Transfer Blot -- 3.1.3. Enzyme Linked Immunosorbent Assay (ELISA) -- 3.1.4. Sandwich ELISA -- 3.1.5. Direct ELISA -- 3.1.6. Antibody ELISA -- 3.1.7. DOT ELISA -- 3.1.8. Molecular Assay and New Age Tools -- 3.1.9. Polymerase Chain Reaction -- 3.1.10. TaqMan PCR -- 3.1.11. Quantitative PCR (qPCR) -- 3.1.12. Multiplex PCR -- 3.1.13. Lymphocyte Transformation Test (LTT) -- 3.1.14. Loop Mediated Isothermal Amplification (LAMP) -- 3.1.15. Magnetic Resonance Spectroscopy (MRS) -- 3.1.16. miRNA -- 3.1.17. Exosome's Detection -- Conclusion -- References -- Trends in the Diagnosis of Human Neurocysticercosis: Issues and Challenges -- Abstract -- Introduction -- Antibody Detection -- Crude Soluble Extract Antigens. Excretory-Secretory Antigens -- Purified Antigenic Fractions -- Recombinant Antigens -- Antigen Detection -- Urine and Saliva Samples -- Nucleic Acid Detection -- Polymerase Chain Reaction (PCR) -- Loop-Mediated Isothermal Amplification (LAMP) -- Genotype Variation in the Parasite -- Proteomics -- Cell Mediated Techniques -- Clinical Considerations -- Presentation vs. Diagnosis -- Single vs. Multiple Lesions -- Childhood NCC -- Post-Treatment Follow-Up -- Conclusion -- References -- Index -- Blank Page. Central nervous system. http://id.loc.gov/authorities/subjects/sh85021906 Cysticercosis. http://id.loc.gov/authorities/subjects/sh85035207 Central Nervous System https://id.nlm.nih.gov/mesh/D002490 Cysticercosis https://id.nlm.nih.gov/mesh/D003551 Système nerveux central. Cysticercose. Central nervous system fast Cysticercosis fast Chavez, Mark A., editor. Print version: Neurocysticercosis New York : Nova Science Publishers, [2021] 9781536197914 (DLC) 2021030101 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2944021 Volltext |
| spellingShingle | Neurocysticercosis : from diagnosis to treatment / Intro -- Contents -- Preface -- Treatment of Neurocysticercosis: Current and Future Options -- Abstract -- Introduction -- Life Cycle -- Clinical Manifestations of NCC -- Pathology of NCC -- Extraparenchymal NCC -- Other forms of NCC -- Existing Treatment -- Symptomatic Therapy -- Corticosteroids -- Antiepileptic Drugs (AEDs) -- Anti-Parasitic/Cysticidal Therapy -- Surgery -- Limitations of Approved Cysticidal Drugs -- Repositioned Drugs -- Nitazoxanide -- Mepacrine/Quinacrine -- Tribendimidine -- Paromomycin -- Tamoxifen -- Metrifonate (Trichlorfon) -- Potential/Novel Drug Targets -- Protein Kinases -- Proteases -- Estrogen Receptor-Like Proteins -- Insulin Receptors -- Acetylcholinesterase's -- G-Protein-Coupled Receptors -- Parasite Antioxidant Enzyme -- Plasminogen and Plasmin -- Future Perspectives -- References -- The Challenge of Deciphering Certainty from Ambiguity for the Laboratory Diagnosis of Neurocysticercosis -- 1. Introduction -- 2. Guidelines for NCC Diagnosis -- 3. Available Diagnostic Tools for NCC -- 3.1. Neuroimaging Techniques (MRI and CT) -- 3.1.1. Sero-Diagnostic Tools -- 3.1.2. Enzyme Electro-Immune Transfer Blot -- 3.1.3. Enzyme Linked Immunosorbent Assay (ELISA) -- 3.1.4. Sandwich ELISA -- 3.1.5. Direct ELISA -- 3.1.6. Antibody ELISA -- 3.1.7. DOT ELISA -- 3.1.8. Molecular Assay and New Age Tools -- 3.1.9. Polymerase Chain Reaction -- 3.1.10. TaqMan PCR -- 3.1.11. Quantitative PCR (qPCR) -- 3.1.12. Multiplex PCR -- 3.1.13. Lymphocyte Transformation Test (LTT) -- 3.1.14. Loop Mediated Isothermal Amplification (LAMP) -- 3.1.15. Magnetic Resonance Spectroscopy (MRS) -- 3.1.16. miRNA -- 3.1.17. Exosome's Detection -- Conclusion -- References -- Trends in the Diagnosis of Human Neurocysticercosis: Issues and Challenges -- Abstract -- Introduction -- Antibody Detection -- Crude Soluble Extract Antigens. Excretory-Secretory Antigens -- Purified Antigenic Fractions -- Recombinant Antigens -- Antigen Detection -- Urine and Saliva Samples -- Nucleic Acid Detection -- Polymerase Chain Reaction (PCR) -- Loop-Mediated Isothermal Amplification (LAMP) -- Genotype Variation in the Parasite -- Proteomics -- Cell Mediated Techniques -- Clinical Considerations -- Presentation vs. Diagnosis -- Single vs. Multiple Lesions -- Childhood NCC -- Post-Treatment Follow-Up -- Conclusion -- References -- Index -- Blank Page. Central nervous system. http://id.loc.gov/authorities/subjects/sh85021906 Cysticercosis. http://id.loc.gov/authorities/subjects/sh85035207 Central Nervous System https://id.nlm.nih.gov/mesh/D002490 Cysticercosis https://id.nlm.nih.gov/mesh/D003551 Système nerveux central. Cysticercose. Central nervous system fast Cysticercosis fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85021906 http://id.loc.gov/authorities/subjects/sh85035207 https://id.nlm.nih.gov/mesh/D002490 https://id.nlm.nih.gov/mesh/D003551 |
| title | Neurocysticercosis : from diagnosis to treatment / |
| title_auth | Neurocysticercosis : from diagnosis to treatment / |
| title_exact_search | Neurocysticercosis : from diagnosis to treatment / |
| title_full | Neurocysticercosis : from diagnosis to treatment / Mark A. Chavez, editor. |
| title_fullStr | Neurocysticercosis : from diagnosis to treatment / Mark A. Chavez, editor. |
| title_full_unstemmed | Neurocysticercosis : from diagnosis to treatment / Mark A. Chavez, editor. |
| title_short | Neurocysticercosis : |
| title_sort | neurocysticercosis from diagnosis to treatment |
| title_sub | from diagnosis to treatment / |
| topic | Central nervous system. http://id.loc.gov/authorities/subjects/sh85021906 Cysticercosis. http://id.loc.gov/authorities/subjects/sh85035207 Central Nervous System https://id.nlm.nih.gov/mesh/D002490 Cysticercosis https://id.nlm.nih.gov/mesh/D003551 Système nerveux central. Cysticercose. Central nervous system fast Cysticercosis fast |
| topic_facet | Central nervous system. Cysticercosis. Central Nervous System Cysticercosis Système nerveux central. Cysticercose. Central nervous system |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2944021 |
| work_keys_str_mv | AT chavezmarka neurocysticercosisfromdiagnosistotreatment |